Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients - Cabibbo, G; Celsa, C; Calvaruso, V (J Hepatol, 2019)
, et al; Rete Sicilia Selezione Terapia—HCV (RESIST-HCV) and Italian Liver Cancer (ITA.LI.CA.) Group.